pharmaceutical companies in Nigeria
pharmaceutical exporters

Developing Pharmaceutical Industry in Africa

The African pharmaceutical market is developing at a rapid speed due to changing economic profiles, growing investment in healthcare, rapid urbanization, and increase in chronic lifestyle diseases. In 2013, the pharmaceutical industry’s value touched $20.8 billion. Multinational pharma companies got a good chance to boost and expand their business. Also, patients gained access to world-class medicines that were not available earlier.

The tropical climate is responsible for various infectious diseases:

The continent encounters infectious diseases like tuberculosis, malaria, AIDs, polio, cholera, yellow fever, meningitis, pandemic influenza, hepatitis, measles, tetanus, etc. There is a visible shift towards non-communicable diseases due to the growing adoption of western lifestyle in Africa, Nigeria, etc.

The pharmaceutical companies in Nigeria, Africa, etc. are manufacturing and importing generic and prescription drugs from other countries. Certain lifestyle diseases including cancer, cardiovascular ailments, diabetes, etc. are growing at a high rate. According to the prediction of the World Health Organization, the NCDs’ proportional contribution to the healthcare burden in these nations will grow by 21% by 2030.

The transitional phase of Africa and Nigeria:

Currently, the nations are in a transitional phase. They are looking forward and working hard towards adherence to certain global standards like the WHO pre-qualification to manufacture. Local production by the top 20 pharmaceutical companies in Nigeria, Africa, etc. is considered as the main strategy for persistent access to high-quality medicines for the long term.

Again, the regulatory environment for medicine production in East Africa is rapidly growing due to the regional harmonization. Experts are expecting expansion of healthcare coverage to a greater number of people through the initiatives of National Health Insurance and through memberships with providers of Private Health Insurance.

The rising popularity of generic medicines:

Generic drugs are getting more market share in Nigeria, South Africa, Kenya, Algeria, Egypt, and Morocco. Between the year 2010 and 2014, the share of generic drugs’ market raised from 22 to 25 percent in Algeria. In Morocco, the rise was from 23 to 28 percent. The pharmaceutical exporters in Africa are finding various factors.

  • The pharmacists and physicians are getting habituated to prescription drugs.
  • There is an expansion of national insurance programs.
  • Many people are gaining access to modern healthcare.
  • The demands for generic drugs are growing instead of costly branded medicines.
  • Governments are displaying strong support for generic medicines. In South Africa, pharmacists are informing private patients about these medicines while they are buying prescription drugs. Again, Nigeria is also following similar law.

 

The business environment is changing:

Governments have taken various initiatives like introducing price controls, import restrictions to give way to the manufacturing of domestic drugs. Country-specific labelling is required for reduction of parallel imports and counterfeiting. Again, the government has initiated stricter laws on import, retail margins and wholesale.

Pharma manufacture in Nigeria, Africa and other locations is on a steady rise. Several joint ventures, partnerships, merging, strategic alliances and private-equity deals are taking place and expanding the present market.

Presently, South Africa is the most superior region for products of medicines in Sub-Saharan Africa. The local market of pharmaceutical manufacturing in East and West Africa are likely to develop. Majority of Africa-based pharmaceutical firms are producing medicines having simple mixtures and formulations.

Technological development is crucial for the development of the manufacturing sector in Nigeria and Africa mainly due to the change in disease burden. Nowadays, the nations are adopting complex formulations aligning with treatment guidelines related to AIDS, HIV, and NCDs.

Grounds of the pharmaceutical industry in African countries:

The pharmaceutical markets in African countries are growing in all sectors. In the recent past till last year, there was a steady growth of prescription drugs, generic medicines, over the counter medicines and lots of medical devices.

The driving grounds are:

Speedy urbanization: The population of Africa is currently passing through a tremendous shift. It is estimated that by the year 2025, around two-fifth of the total economic growth will arrive from 30 cities that consist of around 2 million people. Again, 22 of these cities can have excess GDP of around $20 billion. These cities are likely to enjoy better healthcare and logistics infrastructure. The urban people have more buying capabilities and they can adopt modern best-in-class medicines.

The infrastructure of healthcare: Africa has added 70,000 hospital beds, 16,000 good doctors and 60,000 trained nurses between 2005 and 2012. The provision of healthcare is becoming more methodical via various initiatives. Moreover, the origination of avant-garde delivery models is boosting the capacity.

African pharma market has a better future:

Africa is not a single unified market. It is consisting of 54 distinct markets embracing wide gaps between countries in respect to a growth trajectory, market size, legal structure, macroeconomic landscape, and political complexities. The number of households interested in consuming world-class medicines is increasing. Hence, the pharmaceutical companies in Nigeria and pharmaceutical exporters in Africa are focusing on providing more quality medicines to all.

Make a Call: +91 9979382527
Mail us at [email protected]

Pharmaceutical Companies in Qatar Fulfilling Growing Medicine Demands
Pharmaceutical Company

Pharmaceutical Companies in Qatar Fulfilling Growing Medicine Demands

A drug or pharmaceutical company refers to a commercial business that is licensed for researching, developing, testing, marketing and distributing medicines to the healthcare sector. These companies deal with both generic and brand medications.  They have to follow a particular set of rules and regulations in relation to testing, patenting, marketing, etc.

The generic medicine supplier has become one of the most influential and profit-making hubs since the beginning of the 19th century. Amidst an array of controversy and praises, the pharma industry has become a necessity for the entire world.

Qatar is shining bright in pharma sphere:

There is a process known as drug discovery that deals with the discovery and designing of drugs. In earlier days, the majority of drugs were used to get discovered by the identification of active ingredients through the source of traditional remedies. Also, there was a serendipitous discovery.

In Middle East, USA, UK, India, etc., a newer approach is being taken to understand the way molecular and physiological level control disease and infection for targeting particular entities. In order to make the process faster, new technologies and systems of informatics and data management have been employed. Development of drugs is intensive and expensive and these countries are coping effectively.

Moreover, the investigation is done on various compounds and their use in humans. Approval has been given to a small fraction. Determining the efficacy and safety of the compounds are possible after pre-clinical development, followed by clinical trials and safety monitoring.

The reputed pharmaceutical companies in Qatar are exporting OTC products, nutraceutical medicines and other pharma products that arrive in various forms of dosage. Usually, pharmaceutical products in Qatar consist of tablets, injections, ointments, drops, syrups, sachets, etc.

Many Indian hubs have their branches in Qatar and other nations in the Middle East. These hubs manufacture many drugs at their in-house facilities in India. The US FDA, GMP, ISO 9001, and WHO-GMP certify these facilities.

Qatar is improving performance:

The pharmaceutical manufacturing companies in Qatar are presently involved in the development of a growing portfolio of excellent formulations in the area of health care. They boast a vision of high quality and affordable drugs, generic medicines, etc. and are growing rapidly into a dynamic group.

Qatar is trying to park its surplus that is investible. Again, a country like India is looking forward at investments for funding the growth based on infrastructure. Both the countries can benefit from it.

The general rules for exporting medicines from India to other countries:

  • Drug license off wholesale or manufacturing
  • Import Export Code
  • Current bank account for receiving payment

Requirements for exporting to Arab countries:

GCC approval is required if the products have to be exported to Qatar, Saudi Arabia, UAE, Oman, Bahrain, and Kuwait. Saudi FDA should inspect and approve the manufacturing facility.

The relation between Qatar and India:

The relation between Qatar and India is historic. It is expected that in the year 2023, both the nations will remember the grand 50th anniversary of diplomatic relation’s establishment. Approximately 7 lakhs Indian people reside in Qatar which is the true backbone of the healthy partnership between both nations.

There is a strong bilateral trade relationship between them. It surpassed USD 11 billion in the year 2019-2020. The dominating trade is energy.

The medicine exporters in Qatar strictly stick to national and International Regulatory Requirements along with producing superior products.

The commitment of pharmaceutical companies in Qatar:

The companies are committed to bring continuous improvement and add values to the quality standards for satisfying the needs of customers.

During the Corona Virus pandemic when most of the planes have been grounded throughout the world, on April 2, Qatar Airways Cargo declared that it has started nineteen weekly flights between India and Doha. The initiative is for receiving goods like Pharmaceutical products.

These flights are focused on imparting quality Indian products that have a strong demand in the Middle East such as fresh produce and medicines.

There is a continuation of strong demand for imports and exports, especially related to the transportation of necessary medical supplies that are produced in India and are needed to fight against Corona Virus.

Generic drug supplier is playing a vital role:

India is a country that supplies approximately 1,000 tonnes of APIs to Europe for paracetamol, a common pain reliever. It eases the export controls on OTC medicines that are used for dealing with symptoms of COVID 19.

India is presently the main generic drug supplier. It has shipped around 1.9 million tablets and certain other forms of paracetamol to thirty-one countries. Again, it has added the consignments of paracetamol to be sent to 87 countries commercially.

Countries like the United Arab Emirates, Russia, Jordan, and major partners in Latin America and Africa are likely to export paracetamol from India. Medicine exporters in Qatar are all ready to strengthen the bond with India further to keep on receiving excellent medicines at the most competitive price.

Make a Call: +91 9979382527
Mail us at [email protected]

Generic Medicine Suppliers
Generic Medicine

Generic Medicine Suppliers Serving as World’s Pharmacy

The need of India to produce a huge amount of generic drugs perfectly lines up with its aim to become the most promising bulk, generic drug exporter, to markets of Africa, Qatar, Thailand, etc. Giving importance to this context, the nation has to embrace the economy and focus on producing bulk drugs to give the toughest competition to China and other countries. The government and the private generic medicine supplier are adopting distinct policy measures to generate new formulations and export bulk drugs.

Pharmaceutical as a component:

The trade expansion strategy of India considers pharmaceutical as a key component. The country has an objective in respect to the wider diversification of the medicine export profile given consideration to destination and products.

The global demand of exporting drugs has risen and so the nation is pushing its focus mainly on pharmaceuticals. By 2030, the pharma industry of India is hoping to become the largest drug supplier of the world. The target is to touch a revenue of approximately $120-130 billion at c CAGR of 11-12%. Presently, it is $38 billion.

Posing as world’s pharmacy:

Experts opine that this nation is posing as the world’s pharmacy due to the supply of low priced high-quality drugs in different countries. Medicine exporters in Qatar and other locations order drugs in bulk on a regular basis. The estimation of the government says that India proudly holds the 3rd rank globally for the production of pharmaceutical products by volume. Also, it holds 13th rank in pharmaceutical production by value.

Pharmaceuticals exporters in Africa: Now

According to an estimation, Africa spends approximately $2 billion per year on the treatment of AIDS patients. The executive director of UNAIDS, Michel Sidibé opined that if India would not help, then Africa could not access the treatment of AIDS at $2 billion. Without the presence of India, the cost could reach around $150 billion which is excessively massive.

Additionally, pharmaceutical exporters in Africa or pharma manufacturer in Nigeria are considering tuberculosis and anti-malaria drugs from India. The cost is much less than the medicines supplied by European and US drug suppliers.

In 2015, pharmaceutical exporters in Africa took pharma products that worth around $4 billion. Each year, the generic drug market in Africa is growing at 25 to 30 per cent. The market depends mainly on importing generic drugs.  Hence, the small, mid and good Indian pharmaceutical companies are grabbing this golden opportunity to expand the size and revenue.

Many times, the small pharmaceutical producers in India cannot match the stringent standards imposed by the authorities of Europe and the US. But, it is not the case with Africa, Nigeria, Tanzania, Madagascar, Mozambique, etc. So, the pharmaceutical companies in Nigeria, Africa, and etc. export bulk generic drugs and other pharma products from Indian companies.

Advantage India:

  • Among the top importers of pharma products from India, Nigeria, Qatar, Africa, Thailand, South Africa, USA, Russia, etc. hold prominent name.
  • Right now, generic medicine suppliers in India export around 20 to 22 percent of global export volume.
  • The cost of manufacturing is lower than half of Europe and the entire USA.

Indian pharma manufacturers and suppliers are helping relatively poorer nations like Africa, Nigeria, etc. to deal with tuberculosis, malaria, HIV, and other diseases like presently COVID issues through generic medicines that are low cost. The pharma manufacture in Nigeria is considering India as the key support to get the drugs in bulk for their people.

Thailand pharmaceutical manufacturers seeking India’s support:

Thailand is also wishing to get India’s support in the medical fields like pharmaceutical products and generic drugs. The top pharmaceutical companies in Thailand want to close the big gap between demand and supply of medical devices and pharmaceutical products. It is a major tourist spot. Besides, people from all over the world take treatments from here. India can efficiently fulfil the demands.

Ending with:

Pharma companies in Thailand or top 20 pharmaceutical companies in Nigeria, or any pharma manufacturers and exporters from other nations like Qatar, Africa, and others are depending on India for taking international brand names and generic medicines manufactured in this country. Certain awarded, accredited and trusted firms are ruling this field since long. These firms are committed to offering quality products to global clients.

They act as the one-stop solution for the entire pharmaceutical requirements without any compromise in quality and consistency. The WHO: GMP certified manufacturing plants ensure the products’ quality. The medicine exporters in Qatar, Thailand, Africa and other countries can easily contact these Indian firms online and discuss their requirements and objective. The private sectors and government of these countries are taking initiatives to strengthen the bond with India and exchange help. The authentic Indian firms are providing full value for money at each stage of pharmaceutical production and supply.

Latanoprost & Timolol Eye Drops Latanoprost 50Mcg + Timolo 5Mg
pharmaceutical exporters

A Glance on the Improvement of Today’s Medicine Manufacturers Globally

The market of medicine is always profitable as the demand for medicines will be there as long as humans and animals will exist on earth. But, still there lie certain challenges as generic drugs are considered as cheap and low-quality replacement of branded drugs. Again, patients and doctors are doubtful about the efficacy and safety of these low-cost drugs.

A view on generic drugs:

Generic drugs are supposed to contain the exact active ingredients that are used in the branded formulations. FDA or the U.S. Food and Drug Administration allows identical generics or that are within a justifiable bioequivalent range of the branded counterparts embracing the pharmacodynamic and pharmacokinetic properties.

The top pharma companies that export such medicines and drugs need permission. Exporting controlled drugs such as stimulants, opioids, psychotropic substances, drugs used in lethal injections, etc. must get permission to export to other countries.

Since years, pharmaceutical medicine suppliers are working on various aspects to improve the services.

Steps were taken:

  • The modern pharmaceutical exports hubs are looking for effective ways to raise the marketability. Also, they are focusing on the positioning of their products. It will accelerate the number of release technology formulations that are controlled and entering the market. The companies dealing with drug formulation technology are jointly working with medicine manufacturers for defining the prescription formulations stepping in the preclinical development and furthering to a clinical trial.
  • Again, medicine exporters are ready to face challenges arising in the global pharmaceutical industry. The challenges include complex research aspects, certain developmental and regulatory conditions, fast-changing demands of customers, etc.
  • They are producing a wide range of therapeutic medicines. In fact, they are offering a vast array of dosage forms like controlled-release, injectables, oral solids, liquids, sterile, topicals, semi-solids, high-potency products, and transdermals.
  • They are not missing any opportunity and capitalizing each one of it. It is to deliver high-quality pharma products to a maximum number of pf people worldwide. With a synchronized supply chain augmenting the robust pharmaceuticals development capacity, unique manufacturing as well as vertical integration with Active pharmaceutical ingredients, the companies are creating an estimable track record of launches that are successful.
  • They are increasing the number of state-of-the-art facilities for producing non—sterile oral formulations, sterile powder formulations, APIs, etc. Also, they are building new PD labs and microbiological labs with high-tech equipment.

Other important aspects that prove pharma companies are improving:

Following the guidelines of Good Automated Manufacturing Practice, the top pharma medicine exporters are setting up a fully automated electronically controlled operating system. Besides, they are obeying international environmental, and health and safety regulations.

Actually, the medicine manufacturers and exporters are surpassing their own status and standards with quality assurance. They have an internal team of quality assurance that report directly to the highest regulatory bodies.

They have WHO-GMP certified manufacturing hubs. They are gracefully adopting modern methods including aqueous coating and packing tablets in combi-packs.

Improving quality control and meeting rising demands:

Today’s top-performing medicine manufacturers, for instance, JoinHub Pharma, are extremely focused on quality, complete compliance, 100% safety, and efficiency. The quality control laboratory ensures purity, safety and usefulness of all the products. The employment of highly capable researchers and medicine developers are bringing superior quality via continuous testing at production, packaging, storing, delivering, and exporting levels.

Besides, API analysis and other instruments such as finished products, packaging, relevant materials, etc. are taken care of.

The demands of the healthcare sector are ever-changing. The best pharma manufacturers are playing the crucial role of being the third-party medicine producer and helping the credited houses of Latin America, CIS, Africa, etc. Over 1000 formulations including soft gelatin tablets, powder, soap, injectables, etc. are produced and exported to different nations.

They are striving extremely hard to satisfy their clients from buying the best quality raw materials to dispatching the completed products. The most appreciated part is the unbeatable cost that is making it easier for the outsiders to become loyal customers.

Helping clients to promote business:

Exporting medicines to other countries require certain documents like Free Sales Certificate, COA, MOA, COO, and others. The top pharma companies keep these documents prepared to avoid any mishap during export. Again, nowadays, they are supporting their clients in promoting their business making use of marketing materials such as free samples and goods. Additionally, the companies are promoting sachets, ointments, suppositories, vials, syringe lotion, etc.

Almost all pharma segments for humans and animals are covered which involve generic medicine, hormonal therapy, oncology, innovative molecules, antibodies, and so on.

Execution of purchasing of raw materials, medicine manufacturing, research and development, quality control, medicine testing and packaging, shipping, and final delivery is given prime importance. The pharmaceutical medicine suppliers are maintaining ethics and standards in each step which is progressing them towards being better.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

CALL ME BACK